Congenital Erythropoietic Porphyria - 12 Studies Found
| Completed |
: Hydroxychloroquine and Phlebotomy for Treating Porphyria Cutanea Tarda : Porphyria Cutanea Tarda : 2012-04-05 :
|
| Completed |
: Risk Factors of Porphyria Cutanea Tarda (PCT) : Porphyria Cutanea Tarda : 2005-09-13 |
| Completed |
: Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda : Porphyria Cutanea Tarda : 2008-01-10 : Drug: Deferasirox 250 mg of deferasirox once daily for 6 months |
| Not yet recruiting |
: Studies in Porphyria I: Characterization of Enzyme Defects : Porphyria : 1999-10-18 |
| Completed |
: Study of Nutritional Factors in Porphyria : Porphyria : 2000-02-24 |
| Completed |
: Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks : Porphyria : 1999-10-18 : Drug: luteinizing hormone-releasing factor |
| Active, not recruiting |
: EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP) : Acute Hepatic Porphyria : 2014-09-11 |
| Completed |
: Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria : Porphyria : 1999-10-18 :
|
| Completed |
: Phase I Study of Tin Mesoporphyrin in Patients on Long Term Heme Therapy for Prevention of Acute Attacks of Porphyria : Porphyria : 1999-10-18 :
|
| Completed |
: Safety and Efficacy of Oral Deferasirox in Patients With Porphyria Cutanea Tarda : Porphyria Cutanea Tarda : 2011-01-26 : Drug: Exjade Orodispersible Tablet, 10 mg/Kg/day ± 5 mg/Kg/day during 24 weeks Deferasirox should b |